Apararenone

DB15024InvestigationalSmall molecule

Apararenone is under investigation in clinical trial NCT02531568 (Drug Interaction Study of Warfarin and MT-3995).

Chemical structure of Apararenone
Mechanism
Curator reviewed
Formula / weight
C17H17FN2O4S · 364.39 g/mol (avg)
Code names
MT-3995

Resolves to

Compound
UNII832663U2NBCAS945966-46-1ChEMBLCHEMBL2181929
Structure
InChIKeyAZNHWXAFPBYFGH-UHFFFAOYSA-NSMILESCC1(C)OC2=CC(NS(C)(=O)=O)=CC=C2N(C2=CC=C(F)C=C2)C1=O
Targets
P08235NR3C2

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Apararenone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In